Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Hochberg

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Humoral and cellular immunotherapy in ALL in children, adolescents, and young adultsJessica Hochberg, Nader Kim El-Mallawany, Mitchell S Cairo
British Journal of Haematology|February 7, 2013
Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remissionJessica Hochberg, Samer Khaled, Stephen J Forman, et al.
Best Practice & Research. Clinical Haematology|March 12, 2023
Late effects and frontline treatment selection for children with non-Hodgkin lymphomaMatthew J Ehrhardt, Stephanie B Dixon, Jennifer Belsky, et al.
British Journal of Haematology|February 5, 2019
Long-term survivors of childhood, adolescent and young adult non-Hodgkin lymphomaMatthew J Ehrhardt, Jessica Hochberg, Kari L Bjornard, et al.
British Journal of Haematology|December 18, 2008
Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the scienceJessica Hochberg, Ian M Waxman, Kara M Kelly, et al.
British Journal of Haematology|September 17, 2013
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group ReportPaul J Galardy, Jessica Hochberg, Sherrie L Perkins, et al.
Experimental Hematology|July 30, 2009
Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapyJanet Ayello, Carmella van de Ven, Evan Cairo, et al.
Cancer Immunology Research|December 11, 2014
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG MiceYaya Chu, Jessica Hochberg, Ashlin Yahr, et al.
Oncotarget|March 9, 2018
Ruxolitinib significantly enhances <i>in vitro</i> apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine modelSanghoon Lee, Tishi Shah, Changhong Yin, et al.
Experimental Hematology|October 22, 2016
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapyJanet Ayello, Jessica Hochberg, Allyson Flower, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Humoral and cellular immunotherapy in ALL in children, adolescents, and young adultsJessica Hochberg, Nader Kim El-Mallawany, Mitchell S Cairo
British Journal of Haematology|February 7, 2013
Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remissionJessica Hochberg, Samer Khaled, Stephen J Forman, et al.
Best Practice & Research. Clinical Haematology|March 12, 2023
Late effects and frontline treatment selection for children with non-Hodgkin lymphomaMatthew J Ehrhardt, Stephanie B Dixon, Jennifer Belsky, et al.
British Journal of Haematology|February 5, 2019
Long-term survivors of childhood, adolescent and young adult non-Hodgkin lymphomaMatthew J Ehrhardt, Jessica Hochberg, Kari L Bjornard, et al.
British Journal of Haematology|December 18, 2008
Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the scienceJessica Hochberg, Ian M Waxman, Kara M Kelly, et al.
British Journal of Haematology|September 17, 2013
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group ReportPaul J Galardy, Jessica Hochberg, Sherrie L Perkins, et al.
Experimental Hematology|July 30, 2009
Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapyJanet Ayello, Carmella van de Ven, Evan Cairo, et al.
Cancer Immunology Research|December 11, 2014
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG MiceYaya Chu, Jessica Hochberg, Ashlin Yahr, et al.
Oncotarget|March 9, 2018
Ruxolitinib significantly enhances <i>in vitro</i> apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine modelSanghoon Lee, Tishi Shah, Changhong Yin, et al.
Experimental Hematology|October 22, 2016
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapyJanet Ayello, Jessica Hochberg, Allyson Flower, et al.
Pageof 3